I
Insilico Medicine
Insilico Medicine's AI-generated drug INS018_055 enters Phase II human clinical trials for idiopathic pulmonary fibrosis
Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI
- Reported result:
- ~3 years (2020 discovery to 2023 Phase II) Drug Development Timeline to Phase II
- Deployment timeframe:
- Not reported by source
- Technology:
- Large Language Models & Generative AI
- Vendor:
- Not available in record